全文获取类型
收费全文 | 290篇 |
免费 | 29篇 |
专业分类
319篇 |
出版年
2016年 | 3篇 |
2015年 | 4篇 |
2014年 | 9篇 |
2013年 | 4篇 |
2012年 | 11篇 |
2011年 | 8篇 |
2010年 | 6篇 |
2009年 | 7篇 |
2008年 | 5篇 |
2007年 | 6篇 |
2006年 | 8篇 |
2005年 | 9篇 |
2004年 | 10篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2001年 | 8篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 4篇 |
1994年 | 4篇 |
1992年 | 5篇 |
1989年 | 4篇 |
1988年 | 7篇 |
1987年 | 9篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 4篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1960年 | 5篇 |
1959年 | 3篇 |
1953年 | 3篇 |
1938年 | 4篇 |
1936年 | 9篇 |
1935年 | 5篇 |
1934年 | 2篇 |
1933年 | 8篇 |
1932年 | 9篇 |
1931年 | 9篇 |
1930年 | 2篇 |
1929年 | 7篇 |
1927年 | 2篇 |
1926年 | 2篇 |
1924年 | 2篇 |
1923年 | 3篇 |
1920年 | 3篇 |
1918年 | 3篇 |
1910年 | 2篇 |
排序方式: 共有319条查询结果,搜索用时 31 毫秒
101.
Californium-252 is a neutron-emitting radioisotope used as a brachytherapy source for radioresistant tumors. Presented here are microdosimetric spectra measured as a function of simulated site diameter and distance from applicator tube 252Cf sources. These spectra were measured using miniature tissue-equivalent proportional counters (TEPCs). An investigation of the clinical potential of boron neutron capture (BNC) enhancement of 252Cf brachytherapy is also provided. The absorbed dose from the BNC reaction was measured using a boron-loaded miniature TEPC. Measured neutron, photon and BNC absorbed dose components are provided as a function of distance from the source. In general, the absorbed dose results show good agreement with results from other measurement techniques. A concomitant boost to 252Cf brachytherapy may be provided through the use of the BNC reaction. The potential magnitude of this BNC enhancement increases with increasing distance from the source and is capable of providing a therapeutic gain greater than 30% at a distance of 5 cm from the source, assuming currently achievable boron concentrations. 相似文献
102.
V?Srinivasan GJM?Maestroni DP?Cardinali AI?Esquifino SR?Pandi?Perumal SC?MillerEmail author 《Immunity & ageing : I & A》2005,2(1):17
Aging is associated with a decline in immune function (immunosenescence), a situation known to correlate with increased incidence
of cancer, infectious and degenerative diseases. Innate, cellular and humoral immunity all exhibit increased deterioration
with age. A decrease in functional competence of individual natural killer (NK) cells is found with advancing age. Macrophages
and granulocytes show functional decline in aging as evidenced by their diminished phagocytic activity and impairment of superoxide
generation. There is also marked shift in cytokine profile as age advances, e.g., CD3+ and CD4+ cells decline in number whereas
CD8+ cells increase in elderly individuals. A decline in organ specific antibodies occurs causing reduced humoral responsiveness.
Circulating melatonin decreases with age and in recent years much interest has been focused on its immunomodulatory effect.
Melatonin stimulates the production of progenitor cells for granulocytes-macrophages. It also stimulates the production of
NK cells and CD4+ cells and inhibits CD8+ cells. The production and release of various cytokines from NK cells and T-helper
lymphocytes also are enhanced by melatonin. Melatonin presumably regulates immune function by acting on the immune-opioid
network, by affecting G protein-cAMP signal pathway and by regulating intracellular glutathione levels. Melatonin has the
potential therapeutic value to enhance immune function in aged individuals and in patients in an immunocompromised state. 相似文献
103.
104.
105.
LEN VERWOERD M.SC. AGRIC. 《The Annals of applied biology》1929,16(1):34-39
Experiments are recorded which indicate that from a number of tomato plants raised from mosaic-diseased cuttings, two plants were free from mosaic disease.
These two plants showed no symptoms of mosaic disease and neither was the active principle of the disease present in the juice obtained from these plants. 相似文献
These two plants showed no symptoms of mosaic disease and neither was the active principle of the disease present in the juice obtained from these plants. 相似文献
106.
107.
108.
109.
110.